Hikma Pharmaceuticals, a leading FTSE 100 company in the pharmaceuticals sector, has seen a significant decline in its share price following the announcement of weaker financial forecasts and the scrapping
Hikma Pharmaceuticals, a leading FTSE 100 company in the pharmaceuticals sector, has seen a significant decline in its share price following the announcement of weaker financial forecasts and the scrapping






